Professor Amitava Banerjee (UCL Institute of Health Informatics) is leading an on-going treatment trial called Stimulate-ICP and said "the drugs being tested are probably not tackling the underlying mechanisms of long Covid, but rather the mechanisms of the major symptoms".
Read: Wired
Close
